Increasing evidence has shown that ALDH1A1 can be used as a CSC marker in a panel of cancers, including ovarian cancer252,253, lung cancer254,255, breast cancer257, cervical cancer259, and HCC260. Here, ALDH1A1 is linked to cancer.